Technical Analysis for INZY - Inozyme Pharma, Inc.

Grade Last Price % Change Price Change
B 27.9 5.48% 1.45
INZY closed up 5.48 percent on Friday, January 15, 2021, on 1.25 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical INZY trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Reversal New Highs Setup Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Wide Bands Range Expansion 5.48%
Overbought Stochastic Strength 5.48%
Older End-of-Day Signals for INZY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Genetic Disease Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna

Is INZY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.6499
52 Week Low 16.1
Average Volume 39,617
200-Day Moving Average 0.00
50-Day Moving Average 24.75
20-Day Moving Average 24.61
10-Day Moving Average 25.97
Average True Range 1.93
ADX 15.44
+DI 30.18
-DI 16.82
Chandelier Exit (Long, 3 ATRs ) 23.67
Chandelier Exit (Short, 3 ATRs ) 25.19
Upper Bollinger Band 28.78
Lower Bollinger Band 20.43
Percent B (%b) 0.89
BandWidth 33.95
MACD Line 0.77
MACD Signal Line 0.36
MACD Histogram 0.4074
Fundamentals Value
Market Cap 652.1 Million
Num Shares 23.4 Million
EPS -1.11
Price-to-Earnings (P/E) Ratio -25.20
Price-to-Sales 0.00
Price-to-Book 3.65
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.34
Resistance 3 (R3) 34.14 31.80 33.26
Resistance 2 (R2) 31.80 30.16 31.90 32.90
Resistance 1 (R1) 29.85 29.15 30.83 30.05 32.55
Pivot Point 27.51 27.51 28.00 27.61 27.51
Support 1 (S1) 25.56 25.87 26.54 25.76 23.25
Support 2 (S2) 23.22 24.86 23.32 22.90
Support 3 (S3) 21.27 23.22 22.54
Support 4 (S4) 21.47